Posted Sep. 4, 2013 at 5:09 p.m.

Premium Lock Pozen licenses 'safer aspirin' to Sanofi in deal that could top $35M

Published: 2013-09-04 17:09:43
Updated: 2013-09-04 17:09:43

Diagram from Pozen presentation about PA technology Diagram from Pozen presentation about PA technology

The deal awards $15 million up front to Pozen; the Chapel Hill company stands to gain pre-commercialization milestones of up to $20 million and other future milestones and royalties depending on sales of PA drugs....

Read More
Read More

WRAL TechWire any time: Twitter, Facebook

Copyright 2014 WRAL TechWire. All rights reserved.
Editor's Blog

Editor's Blog

The latest blog posts from our WRAL TechWire and WRAL editors. Read more articles…

Please Log In to add a comment.

Best of TechWire Insider

Techwire Inside Partners

OUR INSIDERS

Frank Vinluan
Life science
Vivek Wadhwa
Commentary
Dr. Mike Walden
Tech economy
Scroll